Early growth response gene 1 (Egr1) is a member of the immediate early gene (IEG) family of transcription factors and plays a role in memory formation. To identify EGR1 target genes in brain of Alzheimer's disease (AD) model mice -APP23, we applied chromatin immunoprecipitation (ChIP) followed by high-throughput DNA sequencing (ChIP-seq). Functional annotation of genes associated with EGR1 binding revealed a set of related networks including synaptic vesicle transport, clathrin-mediated endocytosis (CME), intracellular membrane fusion and transmission of signals elicited by Ca 2+ influx. EGR1 binding is associated with significant enrichment of activating chromatin marks and appears enriched near genes that are up-regulated in the brains of APP23 mice. Among the putative EGR1 targets identified and validated in this study are genes related to synaptic plasticity and transport of proteins, such as Arc, Grin1, Syn2, Vamp2 and Stx6, and genes implicated in AD such as Picalm, Psen2 and App. We also demonstrate a potential regulatory link between EGR1 and its newly identified targets in vivo, since conditions that up-regulate Egr1 levels in brain, such as a spatial memory test, also lead to increased expression of the targets. On the other hand, protein levels of EGR1 and ARC, SYN2, STX6 and PICALM are significantly lower in the brain of adult APP mice than in age-matched wild type animals. The results of this study suggest that EGR1 regulates the expression of genes involved in CME, vesicular transport and synaptic transmission that may be critical for AD pathogenesis.
Introduction
Early growth response gene-1 (Egr1 in mice, EGR1 in humans) (Beckmann and Wilce, 1997) is considered a key transcriptional regulator linking injurious stimuli to the induction of effector molecules. With sustained or increased chronic EGR1 activation the response may ultimately result in cardiovascular pathology, or sclerosis that is either systemic (scleroderma) or organ specific (e.g. in liver or lung) (Bhattacharyya et al., 2013; Silverman and Collins, 1999) . EGR1 is an activity-dependent IEG transcription factor, which is up-regulated within minutes following a variety of memory tests (Miyashita et al., 2009; Miyashita et al., 2008) . In the hippocampal CA3-established ensembles of place cells, increased mRNA synthesis of Egr1 and a small number of known gene targets, including Synapsin I and Synapsin II (Syn1, Syn2) and activity-regulated cytoskeleton associated protein (Arc), provides a mean for fast encoding of experiences (Knapska and Kaczmarek, 2004; Kubik et al., 2007) . Until now, research related to the biology of EGR1 in CNS has been concentrated either on behavioral paradigms that lead to Egr1 up-regulation (Davis et al., 2010; Knapska and Kaczmarek, 2004; Poirier et al., 2008) , or identification of regulatory pathways involved in transcriptional up-regulation of Egr1 (Ritchie et al., 2011; Thiel and Cibelli, 2002; Thiel et al., 2010) . Downregulation of Egr1 has been reported in AD model mice -APP/PS1, at a time when these mice exhibit cognitive deficits (Dickey et al., 2004; Dickey et al., 2003) . It has been found, however, that in conditions of environmental enrichment, APP/PS1 mice respond by elevated expression of IEGs, including Egr1(Lazarov et al., 2005) . So far EGR1 target genes and regulatory networks in the brain of model mice in the context of neurodegeneration have not been systematically explored. Using ChIP-seq we mapped genome-wide EGR1 binding in brain tissue of APP-expressing mice. We demonstrate that binding of EGR1 in close proximity to the transcription start sites of putative target genes correlates to enhanced histone acetylation and methylation indicative of transcriptional activity. Remarkably, the annotated
